Tags

Type your tag names separated by a space and hit enter

Anaerobic exercise in pediatric cystic fibrosis.
Pediatr Pulmonol 2003; 36(3):223-9PP

Abstract

Anaerobic fitness is important for daily functioning of children with cystic fibrosis (CF). The aim of this study was to assess the determinants of anaerobic performance in CF. Anaerobic performance was measured in 39 children with CF (mean age, 13.2 +/- 1.8 (SD) years, forced expired volume in 1 sec (FEV(1)) 81.6 +/- 22.1% predicted), using a Wingate anaerobic test. Significant associations were found for peak power (PP) and mean power (MP) with fat-free mass (FFM) body weight, body mass index, maximal isometric muscle force, and aerobic capacity. Pulmonary function was correlated with anaerobic indices when controlled for FFM. Multiple regression analysis indicated that FFM and FEV(1) accounted for 82% and 86% of the variability in PP and MP, respectively. Patients with moderate CF (FEV(1) < 80%), as compared to mild CF (FEV(1) >/= 80%), had higher PP (difference = 85 W, 95% CI = 27-144 W) and MP (difference = 53 W, 95% CI = 42-63 W) at equivalent FFM. Our results indicate that FFM and pulmonary function are important determinants of anaerobic exercise performance in children with CF. With progression of pulmonary disease, anaerobic performance may be enhanced.

Authors+Show Affiliations

Department of Pediatric Physical Therapy, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. pklijn@heideheuvel.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

12910584

Citation

Klijn, Peter H., et al. "Anaerobic Exercise in Pediatric Cystic Fibrosis." Pediatric Pulmonology, vol. 36, no. 3, 2003, pp. 223-9.
Klijn PH, Terheggen-Lagro SW, Van Der Ent CK, et al. Anaerobic exercise in pediatric cystic fibrosis. Pediatr Pulmonol. 2003;36(3):223-9.
Klijn, P. H., Terheggen-Lagro, S. W., Van Der Ent, C. K., Van Der Net, J., Kimpen, J. L., & Helders, P. J. (2003). Anaerobic exercise in pediatric cystic fibrosis. Pediatric Pulmonology, 36(3), pp. 223-9.
Klijn PH, et al. Anaerobic Exercise in Pediatric Cystic Fibrosis. Pediatr Pulmonol. 2003;36(3):223-9. PubMed PMID: 12910584.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anaerobic exercise in pediatric cystic fibrosis. AU - Klijn,Peter H, AU - Terheggen-Lagro,Suzanne W, AU - Van Der Ent,Cornelis K, AU - Van Der Net,Janjaap, AU - Kimpen,Jan L, AU - Helders,Paul J, PY - 2003/8/12/pubmed PY - 2003/12/17/medline PY - 2003/8/12/entrez SP - 223 EP - 9 JF - Pediatric pulmonology JO - Pediatr. Pulmonol. VL - 36 IS - 3 N2 - Anaerobic fitness is important for daily functioning of children with cystic fibrosis (CF). The aim of this study was to assess the determinants of anaerobic performance in CF. Anaerobic performance was measured in 39 children with CF (mean age, 13.2 +/- 1.8 (SD) years, forced expired volume in 1 sec (FEV(1)) 81.6 +/- 22.1% predicted), using a Wingate anaerobic test. Significant associations were found for peak power (PP) and mean power (MP) with fat-free mass (FFM) body weight, body mass index, maximal isometric muscle force, and aerobic capacity. Pulmonary function was correlated with anaerobic indices when controlled for FFM. Multiple regression analysis indicated that FFM and FEV(1) accounted for 82% and 86% of the variability in PP and MP, respectively. Patients with moderate CF (FEV(1) < 80%), as compared to mild CF (FEV(1) >/= 80%), had higher PP (difference = 85 W, 95% CI = 27-144 W) and MP (difference = 53 W, 95% CI = 42-63 W) at equivalent FFM. Our results indicate that FFM and pulmonary function are important determinants of anaerobic exercise performance in children with CF. With progression of pulmonary disease, anaerobic performance may be enhanced. SN - 8755-6863 UR - https://www.unboundmedicine.com/medline/citation/12910584/Anaerobic_exercise_in_pediatric_cystic_fibrosis_ L2 - https://doi.org/10.1002/ppul.10337 DB - PRIME DP - Unbound Medicine ER -